Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of
chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both
manifestations of end-organ damage of the metabolic syndrome. Through multiple …

Background & Aims Cardiovascular disease remains the leading cause of death in patients
with nonalcoholic fatty liver disease (NAFLD). Studies examining the association of coronary …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and the
prevalence of non-alcoholic steatohepatitis (NASH) with fibrosis is increasing as the …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide and its incidence is definitely increasing. NAFLD is a metabolic disease with …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
encompasses a spectrum of pathology from simple steatosis to inflammation and significant …

Non-alcoholic fatty liver disease (NAFLD) represents the hepatic expression of the metabolic
syndrome and is the most prevalent liver disease. NAFLD is associated with liver-related …

Nonalcoholic fatty liver disease (NAFLD) is a multisystemic disease and a rapidly growing
cause of chronic liver disease in children and adults worldwide. Diagnosis and management …

Background & aims We aimed to investigate the effect of the Mediterranean diet (MedDiet)
on cardiovascular risk factors in patients with non-alcoholic fatty liver disease (NAFLD) …